28 February, 2024: Investor meeting with Økonomisk Ugebrev, Copenhagen

Sprint Bioscience’s CEO Johan Emilsson will present the company at Økonomisk Ugebrev’s meeting for investors on February 28 in Copenhagen. Read more about Økonomisk Ugebrev here and the program for the meeting can be found here.